Sustainability Focus Suanfarma is investing in wastewater treatment, photovoltaic solar panels, and utilities upgrading as part of its sustainability commitments. This signals openness to partnerships that enhance environmental performance, cost savings, and regulatory compliance in manufacturing operations.

Global CDMO Reach With 12 local offices and 400+ customers across 70+ countries, Suanfarma has an established global footprint ideal for pharma companies seeking scalable API development, fermentation and chemical synthesis, and cross-border supply capabilities.

Leadership Transition New CEO Pere Mañé Godina appointed in 2025, suggesting a potential strategic shift or acceleration in growth initiatives, partnerships, and product portfolio expansion suitable for targeted executive conversations.

Nutraceutical Growth Acquisition by ArchiMed and the branding of SuanNutra as a globally recognized leader in nutraceutical ingredients indicate opportunities to cross-sell high-quality ingredients and contract development services to nutraceutical players and associated brands.

Innovation Partners Active collaboration on anti-infective API development through precision fermentation and partnerships with Reyoung highlight a readiness to engage in co-development programs, enabling pharma and biotech customers to accelerate innovative product pipelines.